Role of signal transducer and activator of transcription 5 in nucleophosmin/anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells
M. Nieborowska-skorska et al., Role of signal transducer and activator of transcription 5 in nucleophosmin/anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells, CANCER RES, 61(17), 2001, pp. 6517-6523
The NPM/ALK fusion gene, formed by the t(2;5) translocation in anaplastic l
arge-cell lymphoma, encodes a M-r 75,000 hybrid protein that contains the a
mino-terminal portion of the nucleolar phosphoprotein nucleophosmin (NPM) j
oined to the entire cytoplasmic portion of the receptor tyrosine kinase ana
plastic lymphoma kinase (ALK). NPM/ALK encodes a constitutively activated t
yrosine kinase that belongs to the family of tyrosine kinases activated by
chromosomal translocation. Our studies show that NPM/ALK, similar to other
members of this family, activates signal transducer and activator of transc
ription 5 (STAT5) and that this activation is essential for lymphomagenesis
. NPM/WALK-mediated activation of STAT5 was demonstrated by detection of: (
a) constitutive tyrosine phosphorylation and enhanced DNA binding ability o
f STAT5 in NPIWALK-transformed cells; and (b) NPM/WALK-dependent stimulatio
n of STAT5-mediated transactivation of the beta -casein promoter. Retrovira
l infection of NPM/ALK+ cells with a dominant-negative STAT5B mutant (STAT5
-DNM) inhibited the antiapoptotic activity of NPM/WALK in growth factor and
serum-free medium. In addition, STAT5-DNM inhibited proliferation and dimi
nished the clonogenic properties of NPM/WALK-positive cells. Finally, SCID
mice injected with NPM/ALK+ cells infected with a virus carrying STAT5-DNM
survived significantly longer than mice inoculated with NPM/WALK+ cells inf
ected with the empty virus. Necropsy identified a widespread ALK+ lymphoma
in lymph nodes and liver of the affected animals. Together, our data indica
te that NPM/WALK-induced activation of STAT5 may play an important role in
NPM/WALK-mediated lymphomagenesis.